Novel Bile Acid Conjugates for Inflammatory Bowel Disease Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The impact of the human microbiome on bile acid chemistry and its role in health and disease is underexplored, particularly regarding the diverse bile acid conjugates produced by the microbiome, which have profound effects on animal health but have evaded characterization despite extensive research.
Innovation Solution
The use of mass spectrometry informatics and data visualization approaches to assess the impact of the microbiome on mammalian chemistry by comparing metabolomics data from germ-free and specific pathogen-free mice, identifying novel bile acid conjugates that modulate levels of bile acid conjugates, including phenylalanocholic acid, tyrosocholic acid, and leucocholic acid, and their effects on the farnesoid X receptor, with potential therapeutic applications for diseases such as inflammatory bowel disease and liver cancer.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If mass spectrometry informatics and data visualization approaches are used to compare metabolomics data from germ-free and specific pathogen-free mice, then the impact of the microbiome on bile acid chemistry can be comprehensively assessed, but the complexity of the analysis and data processing increases
Solution Approach 1:
The complex metabolomics data is segmented into specific bile acid conjugate categories (e.g., phenylalanocholic acid, tyrosocholic acid, leucocholic acid) allowing systematic analysis of microbiome impacts on different conjugate types separately, improving measurement precision while managing complexity through structured data organization
Solution Approach 2:
Data visualization approaches serve as an intermediary between raw mass spectrometry data and biological insights, transforming complex spectral data into interpretable representations of microbiome impacts on bile acid chemistry, thereby reducing the cognitive load of analyzing high-dimensional data
2Adaptability or versatility
If novel bile acid conjugates are identified and characterized, then therapeutic applications for diseases can be developed, but the time required for characterization and validation increases
Solution Approach 1:
The study preliminarily characterizes novel bile acid conjugates (phenylalanocholic acid, tyrosocholic acid, leucocholic acid) and their FXR agonist activities before therapeutic development, establishing a foundation that accelerates subsequent disease-specific validation and application development
Solution Approach 2:
The identified bile acid conjugates are shown to have broad therapeutic potential across multiple disease types (inflammatory bowel disease, liver cancer, diabetes, atherosclerosis) through their FXR modulation activity, allowing a single discovery to serve multiple therapeutic purposes and justify the characterization time investment
3Reliability
If bile acid conjugates are used to modulate levels of bile acid conjugates in disease states, then treatment effectiveness can be improved, but the difficulty of detecting and measuring changes in bile acid conjugate levels increases
Solution Approach 1:
Mass spectrometry technology replaces traditional, more difficult detection methods with a highly sensitive and specific analytical technique that can accurately measure bile acid conjugate levels and treatment-induced changes, thereby improving reliability while reducing measurement difficulty
Solution Approach 2:
The distinct mass-to-charge ratio signatures of different bile acid conjugates (analogous to color changes for identification) provide unique detection fingerprints that enable reliable measurement and quantification of specific conjugates like phenylalanocholic acid, tyrosocholic acid, and leucocholic acid in complex biological samples
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides a comprehensive understanding of the microbiome's influence on bile acid chemistry and identifies novel bile acid conjugates that can be used to treat various diseases by modulating bile acid levels, offering therapeutic potential for conditions like inflammatory bowel disease and liver cancer.
Implementation Method 1
mass spectrometry informatics and data visualization approaches were used to provide an assessment of the impacts of the microbiome on the chemistry of an entire mammal
Implementation Method 2
These compounds agonized the farnesoid X receptor (FXR) in vitro and a gavage of mice resulted in reduced expression of bile acid synthesis genes in vivo
Data Source
AI summary
Compositions and methods of use for modulating bile acids, including phenylalanocholic acid, tyrosocholic acid and leucocholic acid, to treat diseases, such as inflammatory bowel disease.